Regulon

Regulon: R-2478

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
163.377518Pr-22Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
51056 ENSG00000002549 LAP3 P28838
960 ENSG00000026508 CD44 P16070
1117 ENSG00000064886 CHI3L2 Q15782
9609 ENSG00000100228 RAB36 O95755
57664 ENSG00000105559 PLEKHA4 Q9H4M7
165 ENSG00000106624 AEBP1 Q8IUX7
2633 ENSG00000117228 GBP1 P32455
1950 ENSG00000138798 EGF P01133
3779 ENSG00000145936 KCNMB1 Q16558
26353 ENSG00000152137 HSPB8 Q9UJY1
267 ENSG00000159461 AMFR Q9UKV5
25976 ENSG00000163659 TIPARP C9JXM5
79778 ENSG00000164877 MICALL2 Q8IY33
5209 ENSG00000170525 PFKFB3 Q16875
2275 ENSG00000183386 FHL3 Q13643
6583 ENSG00000197208 SLC22A4 Q9H015

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
TOSEDOSTATANPEPSmall moleculeINHIBITORAminopeptidase inhibitor20
BIVATUZUMABCD44AntibodyBINDING AGENTCD44 antigen binding agent10

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-2478

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-04917ABCC5down-regulatesIRF7activatesR-2478219Drugs (2)

Regulator Drugs (0)

Regulon Drugs (2)

TOSEDOSTAT, BIVATUZUMAB

CMF-06798ATRXdown-regulatesIRF7activatesR-24782119Drugs (2)

Regulator Drugs (0)

Regulon Drugs (2)

TOSEDOSTAT, BIVATUZUMAB

CMF-15791GRM3up-regulatesIRF7activatesR-2478217Drugs (2)

Regulator Drugs (0)

Regulon Drugs (2)

TOSEDOSTAT, BIVATUZUMAB

CMF-16404SUSD5up-regulatesIRF7activatesR-24782112Drugs (2)

Regulator Drugs (0)

Regulon Drugs (2)

TOSEDOSTAT, BIVATUZUMAB

CMF-18704MPP7down-regulatesIRF7activatesR-2478216Drugs (2)

Regulator Drugs (0)

Regulon Drugs (2)

TOSEDOSTAT, BIVATUZUMAB

CMF-21628MUC17up-regulatesIRF7activatesR-24782112Drugs (2)

Regulator Drugs (0)

Regulon Drugs (2)

TOSEDOSTAT, BIVATUZUMAB

CMF-22438IDH1down-regulatesIRF7activatesR-24782120Drugs (2)

Regulator Drugs (0)

Regulon Drugs (2)

TOSEDOSTAT, BIVATUZUMAB

CMF-27677FAM83Hdown-regulatesIRF7activatesR-2478216Drugs (2)

Regulator Drugs (0)

Regulon Drugs (2)

TOSEDOSTAT, BIVATUZUMAB